Literature DB >> 20504226

Autocrine motility factor receptor signaling pathway promotes cell invasion via activation of ROCK-2 in esophageal squamous cell cancer cells.

Lili Wang1, Guiqin Hou, Lexun Xue, Jie Li, Pan Wei, Peirong Xu.   

Abstract

Aberrant overexpression of autocrine motility factor and its receptor (AMFR) is observed in many cancers but not in esophageal squamous cell cancer (ESCC). In this study, upregulated rho-associated protein kinase 2, p-cofilin and intracellular adhesion molecule-1, and downregulated E-cadherin were found in ESCC cells transfected with the plasmid pcDNA 3.1-AMFR-C, while opposite results were observed in ESCC cells transfected with siRNA against AMFR. Additionally, an elevated invasion of ESCC cells by AMFR was reversed by rho-associated protein kinase 2 inhibitor Y-27632, suggesting that AMFR pathway promotes invasion of ESCC cells and may be a potential target for ESCC therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20504226     DOI: 10.3109/07357907.2010.483503

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  11 in total

Review 1.  Long non-coding RNA signatures and related signaling pathway in T-cell acute lymphoblastic leukemia.

Authors:  Homayon Yousefi; Daryush Purrahman; Mohammad Jamshidi; Elena Lak; Bijan Keikhaei; Mohammad-Reza Mahmoudian-Sani
Journal:  Clin Transl Oncol       Date:  2022-07-19       Impact factor: 3.340

2.  Overexpression of S-adenosylhomocysteine hydrolase (SAHH) in esophageal squamous cell carcinoma (ESCC) cell lines: effects on apoptosis, migration and adhesion of cells.

Authors:  Qinghua Li; Lihong Mao; Ruili Wang; Liqiang Zhu; Lexun Xue
Journal:  Mol Biol Rep       Date:  2014-01-16       Impact factor: 2.316

3.  Autocrine motility factor receptor promotes the proliferation of human acute monocytic leukemia THP-1 cells.

Authors:  Yingchao Wang; Lina Ma; Chunmei Wang; Guangyao Sheng; Lei Feng; Chuyun Yin
Journal:  Int J Mol Med       Date:  2015-06-30       Impact factor: 4.101

4.  MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1.

Authors:  Mingxu Song; Yuan Yin; Jiwei Zhang; Binbin Zhang; Zehua Bian; Chao Quan; Leyuan Zhou; Yaling Hu; Qifeng Wang; Shujuan Ni; Bojian Fei; Weili Wang; Xiang Du; Dong Hua; Zhaohui Huang
Journal:  Protein Cell       Date:  2014-08-23       Impact factor: 14.870

Review 5.  Unfolded Protein Response of the Endoplasmic Reticulum in Tumor Progression and Immunogenicity.

Authors:  Yoon Seon Yoo; Hye Gyeong Han; Young Joo Jeon
Journal:  Oxid Med Cell Longev       Date:  2017-12-21       Impact factor: 6.543

6.  Potential role of miR-139-5p in cancer diagnosis, prognosis and therapy.

Authors:  Ling-Li Huang; Ling-Wei Huang; Lei Wang; Ben-Ding Tong; Qing Wei; Xuan-Sheng Ding
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

Review 7.  Migrastatics-Anti-metastatic and Anti-invasion Drugs: Promises and Challenges.

Authors:  Aneta Gandalovičová; Daniel Rosel; Michael Fernandes; Pavel Veselý; Petr Heneberg; Vladimír Čermák; Luboš Petruželka; Sunil Kumar; Victoria Sanz-Moreno; Jan Brábek
Journal:  Trends Cancer       Date:  2017-06

Review 8.  Gp78 E3 Ubiquitin Ligase: Essential Functions and Contributions in Proteostasis.

Authors:  Vibhuti Joshi; Arun Upadhyay; Amit Kumar; Amit Mishra
Journal:  Front Cell Neurosci       Date:  2017-08-25       Impact factor: 5.505

9.  Betulinic Acid Exerts Cytotoxic Activity Against Multidrug-Resistant Tumor Cells via Targeting Autocrine Motility Factor Receptor (AMFR).

Authors:  Mohamed E M Saeed; Nuha Mahmoud; Yoshikazu Sugimoto; Thomas Efferth; Heba Abdel-Aziz
Journal:  Front Pharmacol       Date:  2018-05-15       Impact factor: 5.810

10.  Association between autocrine motility factor receptor gene polymorphism (rs2440472, rs373191257) and glioblastoma multiform in a representative Iranian population.

Authors:  Alireza Eishi Oskouei; Laleh Rafiee; Parvin Mahzouni; Mojgan Gharipour; Shaghayegh Haghjooy Javanmard
Journal:  J Res Med Sci       Date:  2018-11-28       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.